Their findings regarding PD-L1 are consistent with previous results demonstrating increased PD-L1 expression in Burkitt lymphoma and DLBCL secondary to decreased miR-34a expression, which targets PD-L1. The gene discussed is CD274; the disease is Burkitt lymphoma.